EUVIMEDEUVIMED entdecken
Open Access

Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response

Brooke A Pereira iD, Shona Ritchie iD, Cecilia R Chambers iD, Katie A Gordon, Astrid Magenau, Kendelle J Murphy iD, Max Nobis iD, Victoria M Tyma iD, Ying Fei Liew, Morghan C Lucas iD, Marjan M Naeini iD, Deborah S Barkauskas iD und 48 weitere

Science Advances · 05.07.2024 · 10 (27)

DOI: 10.1126/sciadv.adl1197 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 05.07.2024. Verfasst von Brooke A Pereira und 59 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, New South Wales, Australia. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Proteomics. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Cancer Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is characterized by increasing fibrosis, which can enhance tumor progression and spread. Here, we undertook an unbiased temporal assessment of the matrisome of the highly metastatic KPC ( Pdx1-Cre , LSL-Kras G12D/+ , LSL-Trp53 R172H/+ ) and poorly metastatic KP fl C ( Pdx1-Cre , LSL-Kras G12D/+ , Trp53 fl/+ ) genetically engineered mouse models of pancreatic cancer using mass spectrometry proteomics. Our assessment at early-, mid-, and late-stage disease reveals an increased abundance of nidogen-2 (NID2) in the KPC model compared to KP fl C, with further validation showing that NID2 is primarily expressed by cancer-associated fibroblasts (CAFs). Using biomechanical assessments, second harmonic generation imaging, and birefringence analysis, we show that NID2 reduction by CRISPR interference (CRISPRi) in CAFs reduces stiffness and matrix remodeling in three-dimensional models, leading to impaired cancer cell invasion. Intravital imaging revealed improved vascular patency in live NID2-depleted tumors, with enhanced response to gemcitabine/Abraxane. In orthotopic models, NID2 CRISPRi tumors had less liver metastasis and increased survival, highlighting NID2 as a potential PDAC cotarget.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsProteomicsAnimalsHumansMiceCalcium-Binding ProteinsCancer-Associated FibroblastsCell Adhesion MoleculesCell Line, TumorDeoxycytidineDisease Models, AnimalFibrosisGemcitabine

Substanzen

Calcium-Binding ProteinsCell Adhesion MoleculesDeoxycytidineGemcitabineNID2 protein, human

Autor:innen und Institutionen

  • Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, New South Wales, Australia.
  • School of Clinical Medicine, Faculty of Medicine, University of New South Wales (UNSW) Sydney, Kensington, New South Wales, Australia.
  • Intravital Imaging Expertise Center, VIB Center for Cancer Biology, VIB, Leuven, Belgium.
  • Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Genomics and Inherited Disease Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, New South Wales, Australia.

ORCID-Profile: Brooke A Pereira, Shona Ritchie, Cecilia R Chambers, Kendelle J Murphy, Max Nobis, Victoria M Tyma, Morghan C Lucas, Marjan M Naeini, Deborah S Barkauskas, Diego Chacon-Fajardo, Anna E Howell, Sean C Warren, Daniel A Reed, Victoria Lee, Xanthe L Metcalf, Young Kyung Lee, Luke P O'Regan, Michael Trpceski, Angela R M Fontaine, Janett Stoehr, Xufeng Lin, Jessica L Chitty, Sunny Z Wu, Antonia L Cadell, Holly Holliday, Jessica Yang, Michael Papanicolaou, Michael Tayao, Claire Vennin, Julia Yin, Paul J McMillan, Leonard D Goldstein, Ira W Deveson, David R Croucher, Michael S Samuel, Hao-Wen Sim, Marcel Batten, Lorraine Chantrill, Sean M Grimmond, Anthony J Gill, Thomas R Jeffry Evans, Takako Sasaki, Tri G Phan, Owen J Sansom, Jennifer P Morton

Förderung

  • Cancer Research UK

Zitieren

APA

Pereira, B. A., Ritchie, S., Chambers, C. R., Gordon, K. A., Magenau, A., Murphy, K. J., Nobis, M., Tyma, V. M., Liew, Y. F., Lucas, M. C., Naeini, M. M., Barkauskas, D. S., Chacon-Fajardo, D., Howell, A. E., Parker, A. L., Warren, S. C., Reed, D. A., Lee, V., Metcalf, X. L., …, & Australian Pancreatic Cancer Matrix Atlas (APMA) (2024). Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response. Science Advances, 10(27). https://doi.org/10.1126/sciadv.adl1197

Vancouver

Pereira BA, Ritchie S, Chambers CR, Gordon KA, Magenau A, Murphy KJ, et al. Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response. Science Advances. 2024;10(27). doi:10.1126/sciadv.adl1197

BibTeX
@article{Pereira2024,
  author = {Pereira, Brooke A and Ritchie, Shona and Chambers, Cecilia R and Gordon, Katie A and Magenau, Astrid and Murphy, Kendelle J and Nobis, Max and Tyma, Victoria M and Liew, Ying Fei and Lucas, Morghan C and Naeini, Marjan M and Barkauskas, Deborah S and Chacon-Fajardo, Diego and Howell, Anna E and Parker, Amelia L and Warren, Sean C and Reed, Daniel A and Lee, Victoria and Metcalf, Xanthe L and Lee, Young Kyung and O'Regan, Luke P and Zhu, Jessie and Trpceski, Michael and Fontaine, Angela R M and Stoehr, Janett and Rouet, Romain and Lin, Xufeng and Chitty, Jessica L and Porazinski, Sean and Wu, Sunny Z and Filipe, Elysse C and Cadell, Antonia L and Holliday, Holly and Yang, Jessica and Papanicolaou, Michael and Lyons, Ruth J and Zaratzian, Anaiis and Tayao, Michael and Da Silva, Andrew and Vennin, Claire and Yin, Julia and Dew, Alysha B and McMillan, Paul J and Goldstein, Leonard D and Deveson, Ira W and Croucher, David R and Samuel, Michael S and Sim, Hao-Wen and Batten, Marcel and Chantrill, Lorraine and Grimmond, Sean M and Gill, Anthony J and Samra, Jaswinder and Jeffry Evans, Thomas R and Sasaki, Takako and Phan, Tri G and Swarbrick, Alexander and Sansom, Owen J and Morton, Jennifer P and Australian Pancreatic Cancer Matrix Atlas (APMA), Australian Pancreatic Cancer Matrix Atlas (APMA)},
  title = {Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response},
  journal = {Science Advances},
  year = {2024},
  volume = {10},
  number = {27},
  doi = {10.1126/sciadv.adl1197}
}
Kostenlos starten →